SELLAS Life Sciences Gr (NASDAQ: SLS)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-11 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.050 | ||||||
REV | 1.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of SELLAS Life Sciences Gr (NASDAQ: SLS) through any online brokerage.
Other companies in SELLAS Life Sciences Gr’s space includes: Connect Biopharma Hldgs (NASDAQ:CNTB), Celyad Oncology (NASDAQ:CYAD), Evaxion Biotech (NASDAQ:EVAX), Applied Genetic (NASDAQ:AGTC) and OKYO Pharma (NASDAQ:OKYO).
The latest price target for SELLAS Life Sciences Gr (NASDAQ: SLS) was reported by Cantor Fitzgerald on Tuesday, June 28, 2022. The analyst firm set a price target for 6.00 expecting SLS to rise to within 12 months (a possible 158.62% upside). 2 analyst firms have reported ratings in the last year.
The stock price for SELLAS Life Sciences Gr (NASDAQ: SLS) is $2.32 last updated Today at July 5, 2022, 6:23 PM UTC.
There are no upcoming dividends for SELLAS Life Sciences Gr.
SELLAS Life Sciences Gr’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for SELLAS Life Sciences Gr.
SELLAS Life Sciences Gr is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.